Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Oncobiologics announces completion of clinical dosing for bevacizumab (Avastin biosimilar) candidate

CRANBURY, N.J., April 15, 2015 /PRNewswire/ — Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing biosimilars, today announced that clinical development for ONS-1045, an Avastin®/bevacizumab biosimilar candidate, is underway with dosing completed in its pivotal pharmacokinetic (PK) study.  This study is currently being conducted at the Center for Human Drug Research (CHDR) in Leiden, […]

Read More »

Childhood trauma may raise risk of type 1 diabetes

Traumatic events during childhood may increase kids’ risk of developing type 1 diabetes, a Swedish study suggests. The researchers questioned more than 10,000 families and found that children who experienced an extremely stressful life event – like divorce, illness or death in the family – were about three times more likely to develop type 1 […]

Read More »

Approved Pfizer breast cancer drug impresses in latest study

The Pfizer logo is seen at their world headquarters in New York April 28, 2014. Reuters/Andrew Kelly Pfizer Inc said on Wednesday the first formal late-stage trial of its approved treatment for advanced breast cancer, Ibrance, was stopped early after the medicine met its goal of delaying progression of the disease in previously treated patients. […]

Read More »

ReSound Develops First Hearing Aid App for Apple Watch

COPENHAGEN, Denmark–(BUSINESS WIRE)–Today, ReSound introduced the first hearing aid app designed specifically for Apple Watch. Available immediately to Apple Watch wearers, the ReSound Smart™ app for Apple Watch offers a new, streamlined user experience, allowing users to take advantage of seamless, on-the-go control, right from their wrist. The ReSound Smart app for Apple Watch marks the latest of the company’s efforts to bring forward-looking solutions […]

Read More »

Marijuana Extract May Help Epilepsy Patients, Study

Medical Marijuana Extract Curbs Seizure Frequency In Early Trial Of Epilepsy Patients Epilepsy Researchers Hope to Replicate Promising Cannabidiol Findings in Randomized Controlled Studies A new study led by epilepsy specialists at NYU Langone Medical Center shows that some children and adults with treatment-resistant epilepsy may benefit from a treatment regimen including cannabidiol, a compound […]

Read More »

Heart chip beats toward better drug screening, personalized medicine

Reuters Health | Tue Apr 14, 2015 5:22pm EDT BY BEN GRUBER BERKELEY, CALIFORNIA – Bioengineers in California have developed a system that allows human heart cells to function outside the body, a development that could potentially prove a powerful tool  for drug development as well as pave the way toward personalizing treatments for patients with heart conditions. […]

Read More »

Pfizer Beams As Cancer Drug Efficacy Stops Trial Early and Analysts Predict Game Changer

4/15/2015 8:43:44 AM Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy  Phase 3 Top-Line Results Show IBRANCE in Combination with Fulvestrant Meets Progression-Free Survival (PFS) Primary Endpoint NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced that […]

Read More »

Heart Attack Risk Jumps After Divorce

A new study shows that after a divorce people have an increased lifetime risk for heart attacks (myocardial infarction). Although previous studies have found that MIs occur more frequently in people who are divorced, this is the first study to prospectively examine the lifetime relationship between divorce and MI. In a paper published in Circulation: Cardiovascular […]

Read More »

Should The FDA Require CV Outcome Studies For Diabetes Drugs Before Approval?

As the waistline of Americans has increased, so has the incidence of Type 2 diabetes. Startling data from the Centers for Disease Control  shows that that prevalence of this disease, which is directly related to obesity, now exceeds 9% in the adult population. It was less than half that rate in 1996. Furthermore, there doesn’t […]

Read More »

Polio Vaccine Found Safe And Effective 60 Years Ago: What Would Salk Think Today?

It was 60 years ago yesterday that the nation heaved an enormous collective sigh of relief. The largest clinical trial for a vaccine in history had concluded, the data had been collected and analyzed, and the results were announced on April 12, 1955, coincidentally the ten-year anniversary of polio sufferer Franklin D. Roosevelt’s death: Jonas […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom